36192219|t|Sevoflurane dose and postoperative delirium: a prospective cohort analysis.
36192219|a|BACKGROUND: Recent trials are conflicting as to whether titration of anaesthetic dose using electroencephalography monitoring reduces postoperative delirium. Titration to anaesthetic dose itself might yield clearer conclusions. We analysed our observational cohort to clarify both dose ranges for trials of anaesthetic dose and biological plausibility of anaesthetic dose influencing delirium. METHODS: We analysed the use of sevoflurane in an ongoing prospective cohort of non-intracranial surgery. Of 167 participants, 118 received sevoflurane and were aged >65 yr. We tested associations between age-adjusted median sevoflurane (AMS) minimum alveolar concentration fraction or area under the sevoflurane timexdose curve (AUC-S) and delirium severity (Delirium Rating Scale-98). Delirium incidence was measured with 3-minute Diagnostic Confusion Assessment Method (3D-CAM) or CAM-ICU. Associations with previously identified delirium biomarkers (interleukin-8, neurofilament light, total tau, or S100B) were tested. RESULTS: Delirium severity did not correlate with AMS (Spearman's rho=-0.014, P=0.89) or AUC-S (rho=0.093, P=0.35), nor did delirium incidence (AMS Wilcoxon P=0.86, AUC-S P=0.78). Further sensitivity analyses including propofol dose also demonstrated no relationship. Linear regression confirmed no association for AMS in unadjusted (log (IRR)=-0.06 P=0.645) or adjusted models (log (IRR)=-0.0454, P=0.735). No association was observed for AUC-S in unadjusted (log (IRR)=0.00, P=0.054) or adjusted models (log (IRR)=0.00, P=0.832). No association of anaesthetic dose with delirium biomarkers was identified (P>0.05). CONCLUSION: Sevoflurane dose was not associated with delirium severity or incidence. Other biological mechanisms of delirium, such as inflammation and neuronal injury, appear more plausible than dose of sevoflurane. CLINICAL TRIAL REGISTRATION: NCT03124303, NCT01980511.
36192219	0	11	Sevoflurane	Chemical	MESH:D000077149
36192219	21	43	postoperative delirium	Disease	MESH:D000071257
36192219	210	232	postoperative delirium	Disease	MESH:D000071257
36192219	460	468	delirium	Disease	MESH:D003693
36192219	502	513	sevoflurane	Chemical	MESH:D000077149
36192219	610	621	sevoflurane	Chemical	MESH:D000077149
36192219	695	706	sevoflurane	Chemical	MESH:D000077149
36192219	708	711	AMS	Chemical	-
36192219	771	782	sevoflurane	Chemical	MESH:D000077149
36192219	811	819	delirium	Disease	MESH:D003693
36192219	830	838	Delirium	Disease	MESH:D003693
36192219	857	865	Delirium	Disease	MESH:D003693
36192219	1003	1011	delirium	Disease	MESH:D003693
36192219	1024	1037	interleukin-8	Gene	3576
36192219	1066	1069	tau	Gene	4137
36192219	1074	1079	S100B	Gene	6285
36192219	1103	1111	Delirium	Disease	MESH:D003693
36192219	1144	1147	AMS	Chemical	-
36192219	1218	1226	delirium	Disease	MESH:D003693
36192219	1238	1241	AMS	Chemical	-
36192219	1313	1321	propofol	Chemical	MESH:D015742
36192219	1409	1412	AMS	Chemical	-
36192219	1666	1674	delirium	Disease	MESH:D003693
36192219	1723	1734	Sevoflurane	Chemical	MESH:D000077149
36192219	1764	1772	delirium	Disease	MESH:D003693
36192219	1827	1835	delirium	Disease	MESH:D003693
36192219	1845	1857	inflammation	Disease	MESH:D007249
36192219	1862	1877	neuronal injury	Disease	MESH:D009410
36192219	1914	1925	sevoflurane	Chemical	MESH:D000077149
36192219	Association	MESH:D000077149	MESH:D009410
36192219	Association	MESH:D003693	4137
36192219	Association	MESH:D000077149	MESH:D007249
36192219	Association	MESH:D003693	3576
36192219	Association	MESH:D003693	6285

